Colette Brady

Partner

Colette is a Partner in our Litigation & Investigations Department and a member of our Life Sciences and Intellectual Property Groups specialising in intellectual property and regulatory law, dealing with both contentious and non-contentious matters.

Recent significant cases and advisory work includes representing/advising:

Genentech Inc in Commercial Court proceedings against Amgen relating to Amgen’s product Mvasi®, a biosimilar of Genentech’s leading cancer drug Avastin®.
Clonmel Healthcare Limited (Irish subsidiary of STADA Arzneimittel AG) in the defence of Commercial Court proceedings issued by Merck Sharpe & Dohme (MSD) with both the preliminary injunction proceedings and substantive proceedings being appealed to the Supreme Court.
MSD in defence of Commercial Court proceedings brought by Bristol Myers Squibb for patent infringement and MSD’s counterclaim for invalidity. This case related to anti-PD-1 antibodies in the field of cancer therapy and MSD’s product Keytruda.
Some of the world’s leading social media and content-sharing platforms and ISPs on copyright strategy.
Vacaciones eDreams (one of Europe’s biggest online travel agencies) in trade mark infringement, passing off and competition law proceedings before the Commercial Court issued by Ryanair against our client and Google.
Uniphar in respect of its defence of trade mark infringement proceedings issued before the Commercial Court.
Guerbet SA in relation Guerbet’s acquisition of Mallinckrodt’s Irish CMDS business in a transaction valued at approximately $270m.

Colette is a regular contributor of articles to publications and is a lecturer in IP on the Law Society’s Diploma and Certificate Programmes. Colette is also a registered Irish and European Trade Mark and Design Attorney.

Ranking & Recommendations

2024 Chambers Europe

“Colette Brady puts her all into a case, is a pleasure to work with and is very hands-on, knowledgeable and experienced.” “Colette Brady is a rising star.”